-
For Xi’s Critics, Trump’s China Visit Is Fuel for Jokes They Can’t Tell
On Threads and other sites, liberal-minded Chinese accounts were mocking the proceedings and offering a rare window into opinions on Xi Jinping and his leadership style.
-
Some Medicare Patients Can Now Get Free CBD
The Trump administration has authorized a test program to see if the cannabis compound can ease some symptoms and reduce health care costs among older patients.
-
Immigration hearing casts two different views of Virginia’s Fairfax County
Republicans accused Fairfax County Commonwealth’s Attorney Steve Descano of allowing people in the country illegally to get away with serious crimes.
-
Supreme Court Rejects Virginia Democrats’ Effort to Reinstate New Voting Map
State officials had asked the justices to step in to allow the state to use a congressional map in the midterms that was drawn by Democrats and recently approved by voters.
-
Will the Iran War Backlash Save Rep. Thomas Massie in Kentucky?
A view from Thomas Massie’s district in Kentucky.
-
Ahead of U.S. 250th Anniversary, More National Guard Troops to Arrive in D.C.
Federal officials say that hundreds of additional agents, officers and National Guard troops will be deployed ahead of the nation’s 250th birthday celebration.
-
With Possible Raúl Castro Indictment, U.S. Eyes Venezuela Playbook
Amid stepped-up surveillance flights, a visit of the C.I.A. director and an energy embargo, the White House is trying to increase pressure on Cuba.
-
Tina Peters, Colorado Election Denier, Will Be Freed by Gov. Jared Polis
Gov. Jared Polis, a Democrat, commuted the sentence of Ms. Peters, a former county clerk serving a nine-year sentence for her role in a plot to examine voting machines after the 2020 election.
-
Archaeologists Find Egyptian Mummy Buried With the ‘Iliad’
For the deceased of Roman-era Egypt, Greek literature may have offered a cheat code to a more comfortable afterlife.
-
What Trump Gained, and Didn’t, From China
President Trump is returning home from Beijing after a two-day summit that achieved a few deals but left investors and analysts underwhelmed.